Excellent removal of knob-into-hole bispecific antibody byproducts and impurities in a single-capture chromatography

Page view(s)
449
Checked on Apr 16, 2024
Excellent removal of knob-into-hole bispecific antibody byproducts and impurities in a single-capture chromatography
Title:
Excellent removal of knob-into-hole bispecific antibody byproducts and impurities in a single-capture chromatography
Journal Title:
Bioresources and Bioprocessing
Publication Date:
04 July 2022
Citation:
Chen, S. W., Hoi, K. M., Mahfut, F. B., Yang, Y., & Zhang, W. (2022). Excellent removal of knob-into-hole bispecific antibody byproducts and impurities in a single-capture chromatography. Bioresources and Bioprocessing, 9(1). https://doi.org/10.1186/s40643-022-00562-y
Abstract:
AbstractBispecific antibodies (bsAbs) are therapeutically promising due to their ability to bind to two different antigens. However, the bsAb byproducts and impurities, including mispaired homodimers, half-antibodies, light chain mispairings, antibody fragments and high levels of high molecular weight (HMW) species, all pose unique challenges to their downstream processing. Here, using two knob-into-hole (KiH) constructs of bsAbs as model molecules, we demonstrate the excellent removal of bsAb byproducts and impurities in a single Protein A chromatography under optimized conditions, including hole–hole homodimer mispaired products which are physicochemically very similar to the target bsAbs and still present even with the use of the KiH format, though at reduced levels. The removal occurs through the incorporation of an intermediate low-pH wash step and optimal elution conditions, achieving ~ 60% monomeric purity increase in a single Protein A step, without the introduction of sequence-specific bsAb modifications to specifically induce differential Protein A binding. Our results also suggest that the higher aggregation propensity of bsAbs may cause aggregation during the column process, hence an optimization of the appropriate loading amount, which may be lower than that of monoclonal antibodies (mAbs), is required. With the use of loading at 50% of 10% breakthrough (QB10) at 6-min residence time, we show that an overall high monomer purity of 92.1–93.2% can be achieved with good recovery of 78.4–90.6% within one capture step, which is a significant improvement from a monomer purity of ~ 30% in the cell culture supernatant (CCS). The results presented here would be an insightful guidance to all researchers working on the purification process development to produce bispecific antibodies, especially for knob-into-hole bispecific antibodies. Graphical Abstract
License type:
Attribution 4.0 International (CC BY 4.0)
Funding Info:
This research is supported by core funding from: BTI
Grant Reference no. : Core Funding
Description:
ISSN:
2197-4365